1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Summary of information on patients, scans, and MBTs
Variable 1.5T 3T Sex Male (total %) 15 (50%) 11 (55%) Female (total %) 15 (50%) 9 (45%) Age (yr) Averagea 60.3 ± 13.1 58.7 ± 15.7 Range 23.4–91.0 27.3–84.5 Time between baseline and follow-up (days) Averagea (per patient) 147 ± 155 132 ± 129 Range 26–676 17–532 Number of ΔMBTs Total 74 76 ΔMBTts 58 67 ΔMBTos 16 9 Averagea (per patient) 4.4 ± 3.1 3.8 ± 3.9 ΔMBT volume (mL) Averagea 2.4 ± 4.0 2.2 ± 3.8 Range 4.0 × 10−3–1.9 × 101 2.0 × 10−2–3.0 × 101 ΔMBT volume change (mL) Averagea 1.5 ± 2.2 2.2 ± 3.5 Range 3.4 × 10−3–3.5 × 101 9.1 × 10−2–2.0 × 101 ΔMBT VCR (%) Averagea 7.0 × 101 ± 29.5 7.6 × 101 ± 1.7 × 101 Range 7.8 × 10−1–1.0 × 102 4.2–1.0 × 102
↵a Average ± SD.